Time to surgical stabilization of rib fractures: does it impact outcomes?

IF 2.1 Q3 CRITICAL CARE MEDICINE
Trauma Surgery & Acute Care Open Pub Date : 2024-07-11 eCollection Date: 2024-01-01 DOI:10.1136/tsaco-2023-001233
Joseph D Forrester, Babak Sarani, Maximilian Peter Forssten, Yang Cao, Frank Hildebrand, Ahmad Mohammad Ismail, Marcelo A F Ribeiro, Shahin Mohseni
{"title":"Time to surgical stabilization of rib fractures: does it impact outcomes?","authors":"Joseph D Forrester, Babak Sarani, Maximilian Peter Forssten, Yang Cao, Frank Hildebrand, Ahmad Mohammad Ismail, Marcelo A F Ribeiro, Shahin Mohseni","doi":"10.1136/tsaco-2023-001233","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Rib fractures are common, morbid, and potentially lethal. Intuitively, if interventions to mitigate downstream effects of rib fractures can be implemented early, likelihood of developing these complications should be reduced. Surgical stabilization of rib fractures (SSRF) is one therapeutic intervention shown to be useful for mitigating complications of these common fractures. Our aim was to investigate for association between time to SSRF and complications among patients with isolated rib fractures undergoing SSRF.</p><p><strong>Methods: </strong>The 2016-2019 American College of Surgeons Trauma Quality Improvement Program (TQIP) database was queried to identify patient >18 years with isolated thoracic injury undergoing SSRF. Patients were divided into three groups: SSRF ≤2 days, SSRF >2 days but <3 days, and SSRF >3 days. Poisson regression, and adjusting for demographic and clinical covariates, was used to evaluate the association between time to SSRF and the primary endpoint, in-hospital complications. Quantile regression was used to evaluate the effects of time to SSRF on the secondary endpoints, hospital and intensive care unit (ICU) length of stay (LOS).</p><p><strong>Results: </strong>Out of 2185 patients, 918 (42%) underwent SSRF <2 days, 432 (20%) underwent SSRF >2 days but <3 days, and 835 (38%) underwent SSRF >3 days. Hemothorax was more common among patients undergoing SSRF >3 days, otherwise all demographic and clinical variables were similar between groups. After adjusting for potential confounding, SSRF >3 days was associated with a threefold risk of composite in-hospital complications (adjusted incidence rate ratio: 3.15, 95% CI 1.76 to 5.62; p<0.001), a 4-day increase in total hospital LOS (change in median LOS: 4.09; 95% CI 3.69 to 4.49, p<0.001), and a nearly 2-day increase in median ICU LOS (change in median LOS: 1.70; 95% CI 1.32 to 2.08, p<0.001), compared with SSRF ≤2 days.</p><p><strong>Conclusion: </strong>Among patients undergoing SSRF in TQIP, earlier SSRF is associated with less in-hospital complications and shorter hospital stays. Standardization of time to SSRF as a trauma quality metric should be considered.</p><p><strong>Level of evidence: </strong>Level II, retrospective.</p>","PeriodicalId":23307,"journal":{"name":"Trauma Surgery & Acute Care Open","volume":"9 1","pages":"e001233"},"PeriodicalIF":2.1000,"publicationDate":"2024-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11243129/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Trauma Surgery & Acute Care Open","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/tsaco-2023-001233","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"CRITICAL CARE MEDICINE","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: Rib fractures are common, morbid, and potentially lethal. Intuitively, if interventions to mitigate downstream effects of rib fractures can be implemented early, likelihood of developing these complications should be reduced. Surgical stabilization of rib fractures (SSRF) is one therapeutic intervention shown to be useful for mitigating complications of these common fractures. Our aim was to investigate for association between time to SSRF and complications among patients with isolated rib fractures undergoing SSRF.

Methods: The 2016-2019 American College of Surgeons Trauma Quality Improvement Program (TQIP) database was queried to identify patient >18 years with isolated thoracic injury undergoing SSRF. Patients were divided into three groups: SSRF ≤2 days, SSRF >2 days but <3 days, and SSRF >3 days. Poisson regression, and adjusting for demographic and clinical covariates, was used to evaluate the association between time to SSRF and the primary endpoint, in-hospital complications. Quantile regression was used to evaluate the effects of time to SSRF on the secondary endpoints, hospital and intensive care unit (ICU) length of stay (LOS).

Results: Out of 2185 patients, 918 (42%) underwent SSRF <2 days, 432 (20%) underwent SSRF >2 days but <3 days, and 835 (38%) underwent SSRF >3 days. Hemothorax was more common among patients undergoing SSRF >3 days, otherwise all demographic and clinical variables were similar between groups. After adjusting for potential confounding, SSRF >3 days was associated with a threefold risk of composite in-hospital complications (adjusted incidence rate ratio: 3.15, 95% CI 1.76 to 5.62; p<0.001), a 4-day increase in total hospital LOS (change in median LOS: 4.09; 95% CI 3.69 to 4.49, p<0.001), and a nearly 2-day increase in median ICU LOS (change in median LOS: 1.70; 95% CI 1.32 to 2.08, p<0.001), compared with SSRF ≤2 days.

Conclusion: Among patients undergoing SSRF in TQIP, earlier SSRF is associated with less in-hospital complications and shorter hospital stays. Standardization of time to SSRF as a trauma quality metric should be considered.

Level of evidence: Level II, retrospective.

手术稳定肋骨骨折的时间:它会影响疗效吗?
目的:肋骨骨折是一种常见病、多发病和潜在的致命性疾病。直观地说,如果能及早采取干预措施减轻肋骨骨折的下游影响,就能降低出现这些并发症的可能性。肋骨骨折手术稳定(SSRF)是一种治疗干预措施,已被证明可有效减轻这些常见骨折的并发症。我们的目的是研究接受 SSRF 的孤立性肋骨骨折患者中,SSRF 的时间与并发症之间的关系:我们查询了 2016-2019 年美国外科学院创伤质量改进计划(TQIP)数据库,以确定接受 SSRF 的 18 岁以上孤立性胸部损伤患者。患者被分为三组:SSRF ≤2天、SSRF >2天但3天。采用泊松回归并调整人口统计学和临床协变量来评估SSRF时间与主要终点(院内并发症)之间的关系。定量回归用于评估SSRF时间对次要终点(住院时间和重症监护室(ICU)住院时间)的影响:在2185名患者中,918人(42%)在2天或3天内接受了SSRF。血气胸在接受 SSRF > 3 天的患者中更为常见,除此之外,各组患者的所有人口统计学和临床变量均相似。调整潜在混杂因素后,SSRF >3天与三倍的院内综合并发症风险相关(调整后发病率比:3.15,95% CI 1.76至5.62;P结论:在 TQIP 中接受 SSRF 的患者中,较早进行 SSRF 与较少的院内并发症和较短的住院时间相关。应考虑将SSRF时间标准化作为创伤质量指标:证据级别:二级,回顾性
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.70
自引率
5.00%
发文量
71
审稿时长
12 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信